Quick improvement of clinical symptoms of statin myopathy but very slow decrease of high creatine kinase level after statin withdrawal in an old osteoporotic female patient
Abstract
Both statins and nitrogen-containing bisphosphonates act via the mevalonate pathway. When used together, not only their beneficial effects but also their side effects may cumulate. Thus, the possibility of rhabdomyolysis in osteoporotic female patients treated with lipid-lowering agents as well was already highlighted in 2009 by Japanese authors. In very rare cases, this side effect has also been observed in chronic statin treatment immediately after bisphosphonate administration. In the case described, creatine kinase levels approaching the threshold for rhabdomyolysis with myopathic symptoms were observed during chronic co-administration of the two drugs. The 81-year-old woman after 18 months of atorvastatin treatment with a dose of 30 mg/day was examined for joint complaints, proximal lower leg muscle pain and muscle weakness of 6 months duration, with creatine kinase level of 5638 U/L and lactate dehydrogenase level of 2129 U/L. After 6 weeks of statin withdrawal, clinical symptoms resolved but creatine kinase levels decreased very slowly being above 7 times the normal upper limit after 5 months. The euthyroid, non-diabetic patient had previously been treated with per os alendronate for 4 years and per os risedronate for almost 1 year (the latter was still given continuously after the presentation), with continuous calcium and vitamin D supplementation throughout. Thus, a statin-bisphosphonate interaction was suspected to be responsible for the development of the high…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.